Literature DB >> 12598915

Angiogenesis relates to estrogen receptor negativity, c-erbB-2 overexpression and early relapse in node-negative ductal carcinoma of the breast.

Michael I Koukourakis1, Costantinos Manolas, George Minopoulos, Alexandra Giatromanolaki, Efthimios Sivridis.   

Abstract

Tumor angiogenic activity is an important process linked to tumor growth, metastasis, and invasion. In the present study we investigated whether intratumoral microvessel density (MVD), as assessed with immunohistochemistry, is of prognostic relevance in a series of 77 breast cancer patients with node-negative disease. The mean MVD in the hot spots ranged from 9 to 106 (median 31) vessels per x200 optical field. Patients were grouped into 3 categories of low (27 pts), medium (26 pts), and high (24 pts) MVD. Angiogenesis was not related to the primary tumor dimensions (T-stage) or the histology differentiation. An inverse association of MVD with estrogen receptor (ER) expression was noted (p=0.0007), while high MVD was directly related to c-erbB-2 overexpression (p=0.04) and high MIB1 proliferation index (p=0.02). In univariate and multivariate analysis of relapse-free survival, MVD was the only variable significantly and independently linked to relapse. It is concluded that high intratumoral angiogenic activity is linked with early relapse in node-negative breast cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12598915     DOI: 10.1177/106689690301100107

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  15 in total

1.  Can proton MRS provide useful information for characterizing estrogen receptor status in breast cancer?

Authors:  H-M Baek; J-H Chen; O Nalcioglu; M-Y Su
Journal:  Ann Oncol       Date:  2009-11-30       Impact factor: 32.976

2.  LC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas.

Authors:  Efthimios Sivridis; Michael I Koukourakis; Christos E Zois; Ioanna Ledaki; David J P Ferguson; Adrian L Harris; Kevin C Gatter; Alexandra Giatromanolaki
Journal:  Am J Pathol       Date:  2010-04-09       Impact factor: 4.307

3.  MRI kinetics with volumetric analysis in correlation with hormonal receptor subtypes and histologic grade of invasive breast cancers.

Authors:  Lester Chee Hao Leong; Eva C Gombos; Jayender Jagadeesan; Stephanie Man Chung Fook-Chong
Journal:  AJR Am J Roentgenol       Date:  2015-03       Impact factor: 3.959

4.  Estrogen receptor and breast MR imaging features: a correlation study.

Authors:  Jeon-Hor Chen; Hyeon-Man Baek; Orhan Nalcioglu; Min-Ying Su
Journal:  J Magn Reson Imaging       Date:  2008-04       Impact factor: 4.813

5.  Augmented inhibition of angiogenesis by combination of HER2 antibody chA21 and trastuzumab in human ovarian carcinoma xenograft.

Authors:  Anli Zhang; Guodong Shen; Ting Zhao; Guihong Zhang; Jing Liu; Lihua Song; Wei Wei; Ling Bing; Zhengsheng Wu; Qiang Wu
Journal:  J Ovarian Res       Date:  2010-08-19       Impact factor: 4.234

6.  Antiangiogenic tetrathiomolybdate protects against Her2/neu-induced breast carcinoma by hypoplastic remodeling of the mammary gland.

Authors:  Quintin Pan; Devin T Rosenthal; Liwei Bao; Celina G Kleer; Sofia D Merajver
Journal:  Clin Cancer Res       Date:  2009-11-24       Impact factor: 12.531

7.  Correlation between three-dimensional ultrasound features and pathological prognostic factors in breast cancer.

Authors:  Jun Jiang; Ya-qing Chen; Yi-zhuan Xu; Ming-li Chen; Yun-kai Zhu; Wen-bin Guan; Xiao-jin Wang
Journal:  Eur Radiol       Date:  2014-04-12       Impact factor: 5.315

8.  Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer.

Authors:  G G Van den Eynden; I Van der Auwera; S J Van Laere; C G Colpaert; H Turley; A L Harris; P van Dam; L Y Dirix; P B Vermeulen; E A Van Marck
Journal:  Br J Cancer       Date:  2005-11-14       Impact factor: 7.640

9.  Pathologic response prediction to neoadjuvant chemotherapy utilizing pretreatment near-infrared imaging parameters and tumor pathologic criteria.

Authors:  Quing Zhu; Liqun Wang; Susan Tannenbaum; Andrew Ricci; Patricia DeFusco; Poornima Hegde
Journal:  Breast Cancer Res       Date:  2014-10-28       Impact factor: 6.466

10.  Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy.

Authors:  Y Nieto; J Woods; F Nawaz; A Baron; R B Jones; E J Shpall; S Nawaz
Journal:  Br J Cancer       Date:  2007-07-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.